Clinical Trials Browser

INDUSTRY × Immunoglobulin Light-chain Amyloidosis × ixazomib × Clear all

NCT01318902 2020-04-01

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Phase 1 Completed

27 enrolled 34 charts

Immunoglobulin Light-chain Amyloidosis